USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression
Letters in Drug Design & Discovery · 2026-03 · 23 (3) · 100423
DOI: 10.1016/j.lddd.2026.100423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-03. Verfasst von Tingting Qi und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
• EPHA2 drives cervical cancer progression by inducing M2 macrophage polarization. • USP13 stabilizes EPHA2 protein by mediating the deubiquitination. • USP13 targets EPHA2 to affect M2 macrophage polarization and cervical cancer cell progression. • USP13/EPHA2 promotes tumor growth and M2 macrophage polarization in vivo .
Zitieren
APA
Qi, T., Zeng, F., Xiong, T., & Sun, L. (2026). USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression. Letters in Drug Design & Discovery, 23(3), 100423. https://doi.org/10.1016/j.lddd.2026.100423
Vancouver
Qi T, Zeng F, Xiong T, Sun L. USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression. Letters in Drug Design & Discovery. 2026;23(3):100423. doi:10.1016/j.lddd.2026.100423
BibTeX
@article{Qi2026,
author = {Qi, Tingting and Zeng, Fanye and Xiong, Tingchuan and Sun, Liting},
title = {USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {3},
pages = {100423},
doi = {10.1016/j.lddd.2026.100423}
}
EUVIMED